Cite
MLA Citation
Z. Kim et al.. “The optimal timing and duration of daily G-CSF for primary prophylaxis after adjuvant TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy in breast cancer patients.” Breast, vol. 44, n.d., pp. S18–. http://access.bl.uk/ark:/81055/vdc_100080181175.0x000022